A solution to poor solubility; Chiasma secures $5.1M;

> Poor solubility is a problem for pharmaceuticals, in general. This paper looks at the promise of solid lipid nanoparticles and nanosuspensions to improve bioavailability of poor water-soluble drugs. More here

> Massachusetts-based protein drug delivery company Chiasma secured $5.1 million in equity and rights-based funding. More

> World Drug Delivery Congress 2011 will be held in Singapore on Sept. 5 to 7. Release

> Drug delivery abstract of the week: A novel nested liposome drug delivery vehicle capable of ultrasound triggered release of its payload. Abstract

> Drug delivery patent of the week: Self-assembling nanoparticle drug delivery system. Patent

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.